12 Jun 2019

VICI VENOUS STENT: FDA OKs VICI Venous Stent to treat Iliofemoral obstructive disease

    The U.S Food and Drug Administration has approved Boston Scientific’s VICI Venous Stent System for the treatment of iliofemoral venous obstructive disease, which occurs when the flow of blood through the veins located deep in the pelvic region becomes blocked by a blood clot or compressed by anatomical anomalies.

0
12 Jun 2019

VECLOSE EXTENSION STUDY: Five-year outcomes prove durability, safety, efficacy of VenaSeal Closure System

    By Larry Storer Five-year results from the 2019 VeClose Extension Study of the Medtronic VenaSeal Closure System demonstrate that the treatment modality is consistent, durable and safe for permanently closing veins in patients with venous reflux disease. When compared with Medtronic Radiofrequency Ablation, VenaSeal continued to show “non-inferiority”

0
12 Jun 2019

MERZ REGAINS SOLE DISTRIBUTION OF ASCLERA FROM ANGIODYNAMICS

  Merz North America Inc. has regained exclusive distribution of Asclera (polidocanol) Injection in the United States to all healthcare practitioners and phlebologists treating varicose veins. Also effective April 8, AngioDynamics Inc. is no longer an authorized distributor of Asclera. All HCPs will now be able to purchase Asclera directly

0
12 Jun 2019

NEVER SAY DIE: WHY MOST DOCTORS WON’T BREAK BAD NEWS

  By JoNel Aleccia After nearly 40 years as an internist, Portland, Oregon physician Ron Naito knew what the sky-high results of his blood test meant. And it wasn’t good. But when he turned to his doctors last summer to confirm the dire diagnosis — stage 4 pancreatic cancer —

0
11 Jun 2019

WHEN IT COMES TO OUR HEALTH – EVERY SECOND COUNTS

By Seema Verma Healthcare: American’s favorite debate topic.  While there is much to debate, we can all agree that the patient-provider relationship has been strained by unnecessary regulations and reporting requirements. Too much regulation has had the unintentional result of putting the government first and the patient second.  Time spent

0
10 Jun 2019

AVLS offers sclerotherapy and hands-on ultrasound courses Aug. 10

            Margaret Mann, MD, FACPh, will conduct the American Vein and Lymphatic Society Sclerotherapy Course Aug. 10 in Arlington, Va.             The Sclerotherapy Course is a comprehensive one-day lecture series, reviewing both the theoretical and practical essentials of sclerotherapy. This course will enhance your sclerotherapy knowledge

0
05 Jun 2019

ANGIODYNAMICS’ NAMIC FLUID SALE TO MEDLINE CLOSES

  Editor’s Note: This June 3 article is an update to an article in the June/July issue of Vein Therapy News. AngioDynamics Inc. has closed the previously announced sale of its NAMIC fluid management portfolio to Medline Industries Inc. on May 31, 2019 for $167.5 million. AngioDynamics has used a portion

0
05 Jun 2019

MAY 28: ANGIODYNAMICS CELEBRATES 15 YEARS ON NASDAQ BY RINGING CLOSING BELL

  When the NASDAQ Stock Market closing bell rang on May 28, it was AngioDynamics’s three most tenured employees who were doing the honors. The May 28 honor commemorated the company’s 15th anniversary on the exchange.   “NASDAQ has provided AngioDynamics with a robust platform to access the public equity

0
21 May 2019

HIDDEN FDA REPORTS MASKED THE SCOPE OF WIDESPREAD HARM FROM FAULTY HEART DEVICE

By Christina Jewett Faced with the possibility that a bout of abnormal heartbeats could end his life, in 2006, Dr. Marc Sicklick had a small device implanted in his chest that would shock it back into rhythm. Soon he would struggle with another life-or-death choice: whether to remove the Sprint Fidelis,

0
16 May 2019

MAY 19: Deductible Relief Day

Deductible Relief Day is May 19. That’s the date by which average spending for people with employer-sponsored health insurance is sufficient to satisfy the average deductible, the amount they must pay out-of-pocket for most health care services before their insurance plan kicks in to help pay the bills, Kaiser Family

0